Assignee
OBE THERAPY BIOTECHNOLOGY
FR·2 granted patents·1 pending application·8 citations·filing 2000–2013
Top patents by PatentIndex Score
3 records- 0170US6942967B1Target for treating athersclerosis, obesity and type II diabetesOBE THERAPY BIOTECHNOLOGY·Filed 2000·Granted Sep 13, 2005·8 cites·10 claims
- 0247US9481709B2Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolismOBE THERAPY BIOTECHNOLOGY·Filed 2013·Granted Nov 1, 2016·0 cites·9 claims
- 0345US2010311690A1Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolismOBE THERAPY BIOTECHNOLOGY·Filed 2008·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →